Get the app!
Back to Trades

JOHNSON & JOHNSON

JNJCIK: 0000200406

JOHNSON & JOHNSON (JNJ) has recorded 50 insider filings from 22 unique insiders, totaling $306.4M in trading activity (net selling). Insiders have sold $83.7M while purchasing $257.7K. Insider sales can reflect personal financial planning rather than a bearish view — always consider the full context. The most active insider by volume is Duato Joaquin. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.

Total Volume
$306.4M
Purchases
$257.7K
Sales
$83.7M
Unique Insiders
22

Recent Insider Trades (50)

REED JOHN CEVP, Innovative Medicine, R&D
Filed May 4, 2026
Other
$0
Schmid TimothyEVP, WW Chair, MedTech
Filed Feb 23, 2026
Sell
$324.8K
1 sale
REED JOHN CEVP, Innovative Medicine, R&D
Filed Feb 18, 2026
Sell
$13.1M
3 sales
Duato JoaquinCEO and Chairman of the Board, Director
Filed Feb 18, 2026
Other
$0
Broadhurst VanessaEVP, Global Corp Affairs
Filed Feb 18, 2026
Sell
$1.5M
1 sale
Taubert Jennifer LEVP, WWC. Innovative Medicine
Filed Feb 18, 2026
Other
$0
Sell
$15.1M
3 sales
Mulholland KristenEVP, Chief HR Officer
Filed Feb 18, 2026
Other
$0
Schmid TimothyEVP, WW Chair, MedTech
Filed Feb 18, 2026
Sell
$5.5M
2 sales
Wolk Joseph JExec VP, CFO
Filed Feb 18, 2026
Sell
$21.8M
4 sales
Wengel Kathryn EEVP, Chief TO and Risk Officer
Filed Feb 18, 2026
Other
$0
Decker Robert JVP Corporate Controller
Filed Feb 18, 2026
Other
$0
Forminard ElizabethEVP, Chief Legal Officer
Filed Feb 18, 2026
Other
$0
Duato JoaquinCEO and Chairman of the Board, Director
Filed Feb 11, 2026
Other
$0
Mulholland KristenEVP, Chief HR Officer
Filed Feb 11, 2026
Other
$0
Decker Robert JVP Corporate Controller
Filed Feb 11, 2026
Other
$0
Forminard ElizabethEVP, Chief Legal Officer
Filed Feb 11, 2026
Other
$0
Schmid TimothyEVP, WW Chair, MedTech
Filed Feb 11, 2026
Other
$0
Wengel Kathryn EEVP, Chief TO and Risk Officer
Filed Feb 11, 2026
Other
$0
Broadhurst VanessaEVP, Global Corp Affairs
Filed Feb 11, 2026
Other
$0
Taubert Jennifer LEVP, WWC. Innovative Medicine
Filed Feb 11, 2026
Other
$0
Mulholland KristenEVP, Chief HR Officer
Filed Feb 9, 2026
Other
$0
Wengel Kathryn EEVP, Chief TO and Risk Officer
Filed Feb 9, 2026
Other
$0
Schmid TimothyEVP, WW Chair, MedTech
Filed Feb 10, 2026
Other
$0
Forminard ElizabethEVP, Chief Legal Officer
Filed Feb 6, 2026
Other
$0
Duato JoaquinCEO and Chairman of the Board, Director
Filed Jan 28, 2026
Sell
$22.1M
2 sales
REED JOHN CEVP, Innovative Medicine, R&D
Filed Oct 20, 2025
Sell
$4.2M
1 sale